K. Kian Ang

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

James A. Bonner, Paul M. Harari, J. Giralt et al. · The Lancet Oncology · 2009 · 2K citations

Advanced Head, Neck Cancer, Radiation Therapy +9

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Karen K. Fu, Thomas F. Pajak, Andy Trotti et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.4K citations

Radiation Medicine, Accelerated Fractionation, Radiation Therapy +10

Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer

K. Kian Ang, Andy Trotti, Adam S. Garden et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 625 citations · Full text

Adaptive Radiotherapy, Surgical Oncology, Time Factors +13

Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation

Xin Huang, Lianghao Ding, Kevin L. Bennewith et al. · Molecular Cell · 2009 · 621 citations · Full text

Systems Biology, Medicine, Tumor Initiation +10

Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

Jay S. Cooper, Qiang Zhang, Thomas F. Pajak et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 589 citations · Full text

Long-term Follow-up, Radiation Therapy, Rtog 9501/Intergroup +10